Evaluation of Dosimetric Parameters and Disease Response After 125Iodine Transperineal Brachytherapy for Low- and Intermediate-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Evaluation of Dosimetric Parameters and Disease Response After 125Iodine Transperineal Brachytherapy for Low- and Intermediate-Risk Prostate Cancer

Published:2009-04 Issue:5 Volume:73 Page:1432-1438
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Morris W. James,Keyes Mira,Palma David,McKenzie Michael,Spadinger Ingrid,Agranovich Alex,Pickles Tom,Liu Mitchell,Kwan Winkle,Wu Jonn,Lapointe Vince,Berthelet Eric,Pai Howard,Harrison Robert,Kwa William,Bucci Joe,Racz Violet,Woods Ryan

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management;Cooperberg;J Clin Oncol,2004

2. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: The Toronto Experience With the Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial;Wallace;J Clin Oncol,2006

3. A population based study of biochemical and survival outcomes following permanent 125 Iodine brachytherapy for low- and intermediate-risk prostate cancer;Morris;Urology,2008

4. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve?;Keyes;Int J Radiat Oncol Biol Phys,2006

5. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: Is dose to the penile bulb important?;Macdonald;Int J Radiat Oncol Biol Phys,2005

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry;Brachytherapy;2023-11

2. MRI-defined treatment margins, urinary toxicity, and PSA response in LDR prostate brachytherapy;Brachytherapy;2022-03

3. Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival;Clinical Oncology;2022-01

4. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement;Brachytherapy;2021-11

5. Prostate brachytherapy under hypnosedation: A prospective evaluation;Brachytherapy;2019-01